R E Buckingham - JoVE Visualize

Showing results (21-30 of 40) with videos related to

Pageof 4

Sort By:

British Journal of Pharmacology|December 22, 1999

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilutionL C Pickavance, M Tadayyon, P S Widdowson, et al.

The Annals of Thoracic Surgery|October 1, 1994

Mitral insufficiency after pericardiectomy for constrictive pericarditisR E Buckingham, A P Furnary, M T Weaver, et al.

Diabetes, Obesity & Metabolism|March 21, 2002

Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker ratsK A Al-Barazanji, R E Buckingham, J R Arch, et al.

Peptides|September 28, 1999

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the ratA C Haynes, B Jackson, P Overend, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1995

Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimbT P Eldershaw, S Rattigan, M A Cawthorne, et al.

Journal of Cardiovascular Pharmacology|July 1, 1986

BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal modelsR E Buckingham, J C Clapham, T C Hamilton, et al.

Diabetes|May 4, 2001

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell deathD T Finegood, M D McArthur, D Kojwang, et al.

The New England Journal of Medicine|July 13, 1978

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fractionB M Alving, Y Hojima, J J Pisano, et al.

Brain Research. Molecular Brain Research|May 18, 2000

Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazoneX J Cai, C A Lister, R E Buckingham, et al.

Arzneimittel-Forschung|April 1, 1991

Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal modelsJ C Clapham, T C Hamilton, S D Longman, et al.

Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:

Pageof 4

British Journal of Pharmacology|December 22, 1999

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilutionL C Pickavance, M Tadayyon, P S Widdowson, et al.

The Annals of Thoracic Surgery|October 1, 1994

Mitral insufficiency after pericardiectomy for constrictive pericarditisR E Buckingham, A P Furnary, M T Weaver, et al.

Diabetes, Obesity & Metabolism|March 21, 2002

Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker ratsK A Al-Barazanji, R E Buckingham, J R Arch, et al.

Peptides|September 28, 1999

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the ratA C Haynes, B Jackson, P Overend, et al.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1995

Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimbT P Eldershaw, S Rattigan, M A Cawthorne, et al.

Journal of Cardiovascular Pharmacology|July 1, 1986

BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal modelsR E Buckingham, J C Clapham, T C Hamilton, et al.

Diabetes|May 4, 2001

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell deathD T Finegood, M D McArthur, D Kojwang, et al.

The New England Journal of Medicine|July 13, 1978

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fractionB M Alving, Y Hojima, J J Pisano, et al.

Brain Research. Molecular Brain Research|May 18, 2000

Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazoneX J Cai, C A Lister, R E Buckingham, et al.

Arzneimittel-Forschung|April 1, 1991

Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal modelsJ C Clapham, T C Hamilton, S D Longman, et al.

Pageof 4